Removes insurance approval delays for HIV drugs

File HB2584 ("Removes insurance approval delays for HIV drugs") is before the Illinois Legislature and has not been decided. Latest step (June 1, 2026): Rule 3-9(a) / Re-referred to Assignments.

Illinois file HB2584, before the Illinois Legislature. Still to be decided as of 2026-06-01.

What it does

Skip the approval wait for HIV prevention and treatment medications Starting January 1, 2027, Illinois residents on Medicaid, commercial insurance, or fee-for-service plans can fill HIV pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP), and treatment prescriptions immediately without waiting for insurer approval.

The bigger picture

Faster PrEP access may expand HIV prevention uptake statewide Removing administrative barriers to PrEP—which prevents infection in high-risk individuals—could increase early access among uninsured or Medicaid-eligible populations and reduce transmission rates over time.

What to watch

Insurers may offset costs through other coverage restrictions While prior authorization is eliminated, insurers could respond by raising copays, narrowing formularies for other drugs, or tightening network pharmacy access—shifting the burden rather than removing it entirely.

Official summary

Amends the Prior Authorization Reform Act and the Illinois Public Aid Code. Provides that a health insurance issuer, the fee-for-service medical assistance program, and a Medicaid managed care organization may not require prior authorization for the following prescription drug types and their therapeutic equivalents approved by the United States Food and Drug Administration: human immunodeficiency virus pre-exposure prophylaxis and post-exposure prophylaxis medication or human immunodeficiency virus treatment medication. Effective January 1, 2027.

How they voted

Yes (74)

No (35)

Did not vote / other (5)

Read the official record for HB2584

See everything up for a vote · This week in Illinois · See what we have filed with the clerk